IOVA

News Why Iovance Biotherapeutics Stock Was Climbing Today

14d ago

News This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?

14d ago

News Why Iovance Biotherapeutics Stock Is Crashing Today

14d ago

News Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?

14d ago

News Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts

14d ago

News Where Will Iovance Biotherapeutics Be in 5 Years?

14d ago

News Why Iovance Biotherapeutics Stock Triumphed on Thursday

14d ago

News Is Iovance Biotherapeutics a Millionaire Maker? - The Motley Fool

14d ago

News The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why

14d ago

News Iovance (IOVA) Up 5% on Updated Data From Melanoma Study

14d ago

News Why Iovance Biotherapeutics Stock Stumbled Today

14d ago

News Iovance slips after Q1 miss amid in-line 2026 outlook

26d ago

News Iovance Biotherapeutics Q1 2026 Earnings Preview

27d ago

News Iovance Biotherapeutics GAAP EPS of -$0.18 in-line, revenue of $86.71M beats by $5.7M

98d ago

News Iovance Biotherapeutics Q4 2025 Earnings Preview

99d ago

News Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer

103d ago

News Top Quant rated bullish small cap stocks among companies with high short interest

111d ago

News Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

136d ago

News Tuukka Paavola appointed as Chief Financial Officer of Bioretec

138d ago

News Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

153d ago

News Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

155d ago

Scanner Unusual volume (z=3.0)

160d ago

Scanner Unusual volume (z=2.9)

163d ago

Scanner Unusual volume (z=2.9)

164d ago

News Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

164d ago